Mariah Smith
Primary Care · College Station, TXNPI 1629674015
Payments from drug & device makers
Across 42 payments — averaging $65.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Atricure, Inc.$239
- Boehringer Ingelheim$223
- Viatris Specialty LLC$100
- Actelion Pharmaceuticals US, Inc.$77
- AstraZeneca$68
- plus $158 from 6 others
What the payments were for
- Travel & lodging$1,29947%
- Food & beverage$1,38850%
- Education$773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 20 | $1,899 |
| Atricure, Inc. | 4 | $239 |
| Boehringer Ingelheim | 7 | $223 |
| Viatris Specialty LLC | 1 | $100 |
| Actelion Pharmaceuticals US, Inc. | 1 | $77 |
| AstraZeneca | 3 | $68 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Itamar Medical Inc | 1 | $28 |
| Merck | 1 | $27 |
| Mylan Specialty L.p. | 1 | $25 |
| 3b Medical, Inc. | 1 | $23 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,550
- ATRICLIP LAA EXCLUSION SYSTEM$136
- OFEV$123
How this compares
$2,764 in reported general payments places this provider in the 85th percentile of 563 primary care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 29 | $378,857 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 306 | $270,013 |
| Spiriva RespimatTiotropium Bromide | 34 | $30,702 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 37 | $30,567 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $19,453 |
| SymbicortBudesonide/Formoterol Fumarate | 47 | $15,699 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $11,830 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $7,476 |
| DuleraMometasone/Formoterol | 16 | $7,407 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $6,639 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 42 | $6,637 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 14 | $6,599 |
| Wixela InhubFluticasone Propion/Salmeterol | 26 | $5,106 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 27 | $4,658 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 138 | $4,411 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Combivent Respimat, Stiolto Respimat | $223 | $423,67488 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $68 | $41,75086 claims |
| MerckDulera | $27 | $7,40716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 563 primary care providers in Texas.
Other primary care in College Station
- Hope OdomCollege Station$10K
- Mary GibbensHouston$42K
- Phillip GulleySan Antonio$23K
- Herbert BautistaDallas$14K
- Roxana RoposGrapevine$13K
- Brandi JoynerLongview$12K
- Steven ParisAustin$10K
- Arlena GraysTomball$9K
- Charlotte BallardSan Antonio$9K
- Hannah LancasterMcKinney$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.